Qube Research & Technologies (QRT)’s HUTCHMED HCM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,925	Closed	-$33K	–	3639
2024 Q2	$33K	Buy	1,925 +1,033	+116%	+$19.1K	﹤0.01%	2809
2024 Q1	$15K	Buy	+892	New	+$13.5K	﹤0.01%	3744
2023 Q1	–	Sell	-84,525	Closed	-$1.25M	–	2730
2022 Q4	$1.25M	Buy	+84,525	New	+$924K	0.01%	1118
2022 Q3	–	Sell	-34,598	Closed	-$437K	–	2704
2022 Q2	$437K	Sell	34,598 -30,014	-46%	-$382K	﹤0.01%	1459
2022 Q1	$1.22M	Buy	+64,612	New	+$1.64M	0.01%	1060
2021 Q2	–	Sell	-13,402	Closed	-$379K	–	2477
2021 Q1	$379K	Buy	+13,402	New	+$427K	0.01%	1333
2019 Q4	–	Sell	-19,395	Closed	-$346K	–	1547
2019 Q3	$346K	Sell	19,395 -605	-3%	-$12.6K	0.23%	135
2019 Q2	$440K	Buy	+20,000	New	+$571K	0.1%	195

Other funds holding HCM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CFM

Catalyst Funds Management Sydney NSW, Australia $591M AUM 71.09% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HCM Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of HUTCHMED (HCM) in Q3 2024, closing a stake of 1,925 shares — an estimated $33K sold.

Qube Research & Technologies (QRT) first reported a position in HCM in Q2 2019 and held it in 8 quarters. The position peaked at $1.25M in Q4 2022. 66 funds tracked by Wall St. Rank hold HCM as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining HUTCHMED position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 1,925 HUTCHMED shares in Q3 2024, an estimated $33K.
Qube Research & Technologies (QRT) first reported a position in HUTCHMED in Q2 2019 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s HUTCHMED position peaked at $1.25M in Q4 2022.
66 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.